Allox, a Barcelona-based drug discovery platform provider, raised $10.5M in Seed funding led by Asabys to expand its capabilities and advance multiple drug discovery programs.
PRIVATEOct 29, 2026
Amount Raised
$10.5 Million
Round Type
Seed
Barcelona
Investors
Institut Català De FinancesCdtiAsabys
Description
Allox, a Barcelona, Spain-based provider of an allosteric drug discovery platform, raised $10.5M in Seed funding. The round was led by Asabys with participation from CDTI and Institut Català de Finances. The company intends to use the funds to scale its platform and strengthen its internal drug discovery team. Allox is developing an AI-enabled platform to systematically discover allosteric drug targets.
Who to call at Allox, and when
A new round usually means Allox is about to hire and buy. The teams that reach out first get the meeting.
An alert the day Allox raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Allox, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Allox. With Fundz connected, it knows.
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
Allox
Location
Barcelona, Catalonia, Spain
About
Allox is a biotechnology company developing an experimental and AI-enabled platform for the systematic discovery of allosteric drug targets. The solution combines high-throughput genetics, experimental biology, and AI to map and discover functional hotspots in protein interactions. It aims to design targeted small-molecule therapeutics against high-value targets, operating as a spin-out of the Centre for Genomic Regulation (CRG).
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Allox raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Barcelona